ATE543522T1 - In vivo geformte matrizen mit natürlichen biologisch abbaubaren polysacchariden und ihre ophthalmischen verwendungen - Google Patents

In vivo geformte matrizen mit natürlichen biologisch abbaubaren polysacchariden und ihre ophthalmischen verwendungen

Info

Publication number
ATE543522T1
ATE543522T1 AT06815019T AT06815019T ATE543522T1 AT E543522 T1 ATE543522 T1 AT E543522T1 AT 06815019 T AT06815019 T AT 06815019T AT 06815019 T AT06815019 T AT 06815019T AT E543522 T1 ATE543522 T1 AT E543522T1
Authority
AT
Austria
Prior art keywords
vivo
natural biodegradable
biodegradable polysaccharides
ophthalmic uses
shaped matrices
Prior art date
Application number
AT06815019T
Other languages
English (en)
Inventor
Signe Varner
Nathan Beeley
Stephen Chudzik
Michael Burkstrand
Original Assignee
Surmodics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Surmodics Inc filed Critical Surmodics Inc
Application granted granted Critical
Publication of ATE543522T1 publication Critical patent/ATE543522T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Surgical Instruments (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06815019T 2005-09-21 2006-09-21 In vivo geformte matrizen mit natürlichen biologisch abbaubaren polysacchariden und ihre ophthalmischen verwendungen ATE543522T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71946605P 2005-09-21 2005-09-21
US79108606P 2006-04-10 2006-04-10
PCT/US2006/036632 WO2007038126A1 (en) 2005-09-21 2006-09-21 In vivo formed matrices including natural biodegradable polysaccharides and ophthalmic uses thereof

Publications (1)

Publication Number Publication Date
ATE543522T1 true ATE543522T1 (de) 2012-02-15

Family

ID=37704299

Family Applications (2)

Application Number Title Priority Date Filing Date
AT06803981T ATE454908T1 (de) 2005-09-21 2006-09-21 In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
AT06815019T ATE543522T1 (de) 2005-09-21 2006-09-21 In vivo geformte matrizen mit natürlichen biologisch abbaubaren polysacchariden und ihre ophthalmischen verwendungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT06803981T ATE454908T1 (de) 2005-09-21 2006-09-21 In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden

Country Status (7)

Country Link
US (2) US20070071792A1 (de)
EP (2) EP1926504B1 (de)
JP (2) JP5226517B2 (de)
AT (2) ATE454908T1 (de)
CA (2) CA2621597C (de)
DE (1) DE602006011764D1 (de)
WO (2) WO2007038126A1 (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8393328B2 (en) 2003-08-22 2013-03-12 BiO2 Medical, Inc. Airway assembly and methods of using an airway assembly
WO2005113034A1 (en) * 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharides coatings for medical articles
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
CA2621595A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
US20080039931A1 (en) * 2006-04-25 2008-02-14 Surmodics, Inc. Hydrophilic shape memory insertable medical articles
JP2009542671A (ja) * 2006-06-28 2009-12-03 サーモディクス,インコーポレイティド 微粒子を含む活性剤溶出マトリックス
US8414526B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en) * 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8430055B2 (en) 2008-08-29 2013-04-30 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414909B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) * 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080154241A1 (en) * 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
US8613753B2 (en) 2007-08-31 2013-12-24 BiO2 Medical, Inc. Multi-lumen central access vena cava filter apparatus and method of using same
US9687333B2 (en) 2007-08-31 2017-06-27 BiO2 Medical, Inc. Reduced profile central venous access catheter with vena cava filter and method
US10376685B2 (en) 2007-08-31 2019-08-13 Mermaid Medical Vascular Aps Thrombus detection device and method
US8668712B2 (en) 2007-08-31 2014-03-11 BiO2 Medical, Inc. Multi-lumen central access vena cava filter apparatus and method of using same
US9039728B2 (en) 2007-08-31 2015-05-26 BiO2 Medical, Inc. IVC filter catheter with imaging modality
EP2039254A1 (de) * 2007-09-14 2009-03-25 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO Induzierbares Freigabemittel in Hybridform
WO2009038783A1 (en) * 2007-09-19 2009-03-26 Surmodics, Inc. Biocompatible foams, systems, and methods
US20090105371A1 (en) * 2007-10-17 2009-04-23 Stephanie Luster-Teasley Controlled release remediation system and composition
EP2219692A2 (de) * 2007-11-13 2010-08-25 Boston Scientific Scimed, Inc. Kombination aus spule und embolischer flüssigkeit zur embolisation
US20100081707A1 (en) * 2008-02-21 2010-04-01 Ali Robin R Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea
CA2722425A1 (en) * 2008-04-28 2009-11-05 Surmodics, Inc. Poly-.alpha.(1-4)glucopyranose-based matrices with hydrazide crosslinking
JP5763525B2 (ja) * 2008-05-07 2015-08-12 サーモディクス,インコーポレイティド 粒子からの核酸複合体の送達
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9198968B2 (en) 2008-09-15 2015-12-01 The Spectranetics Corporation Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8114429B2 (en) 2008-09-15 2012-02-14 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8128951B2 (en) 2008-09-15 2012-03-06 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8257722B2 (en) 2008-09-15 2012-09-04 Cv Ingenuity Corp. Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US7985208B2 (en) * 2008-09-18 2011-07-26 Oasis Research LLC Ring shaped contoured collagen shield for ophthalmic drug delivery
JP2012506478A (ja) * 2008-10-22 2012-03-15 サーモディクス,インコーポレイティド 膨潤性および生分解性を有するポリマーマトリクス並びにその製造方法
CN102325814B (zh) * 2009-01-14 2014-03-12 康奈尔大学 用于生物医学用途的生物可降解型水凝胶的制备
EP2397114B1 (de) * 2009-02-10 2021-06-16 Senju Pharmaceutical Co., Ltd. Ringförmige vorrichtung
US20100318074A1 (en) * 2009-06-10 2010-12-16 Bruno Dacquay Ophthalmic endoillumination using low-power laser light
US8901092B2 (en) 2010-12-29 2014-12-02 Surmodics, Inc. Functionalized polysaccharides for active agent delivery
JP6135896B2 (ja) * 2011-03-25 2017-05-31 Jsr株式会社 高分子ゲル及びその製造方法
US10137280B2 (en) * 2011-06-30 2018-11-27 Incube Labs, Llc System and method for treatment of hemorrhagic stroke
US20140248372A1 (en) 2011-09-19 2014-09-04 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
CA2901753C (en) 2013-03-04 2023-08-22 DERMELLE, LLC d/b/a ETERNOGEN, LLC Injectable in situ polymerizable collagen composition
JP6543431B2 (ja) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションUniversity of Utah Research Foundation 眼内薬物送達デバイスおよび付随する方法
US10525171B2 (en) 2014-01-24 2020-01-07 The Spectranetics Corporation Coatings for medical devices
US10376469B2 (en) 2016-02-17 2019-08-13 Biosphere Medical, Inc. Microspheres containing therapeutic agents and related methods of use
US10653480B2 (en) 2016-04-28 2020-05-19 Biosense Webster (Israel) Ltd. Method for constructing irrigated balloon catheter with flexible circuit electrode assembly
US10638976B2 (en) * 2016-04-28 2020-05-05 Biosense Webster (Israel) Ltd Method of constructing irrigated balloon catheter
US10905329B2 (en) 2016-06-09 2021-02-02 Biosense Webster (Israel) Ltd. Multi-function conducting elements for a catheter
CN113730605A (zh) * 2016-07-21 2021-12-03 波士顿科学国际有限公司 可注射组合物
US11400205B2 (en) 2016-11-23 2022-08-02 Biosense Webster (Israel) Ltd. Balloon-in-balloon irrigation balloon catheter
JP2018153296A (ja) * 2017-03-16 2018-10-04 Jsr株式会社 不飽和化合物を含有する組成物
US12029545B2 (en) 2017-05-30 2024-07-09 Biosense Webster (Israel) Ltd. Catheter splines as location sensors
WO2019035975A1 (en) * 2017-08-16 2019-02-21 Biosphere Medical, Inc. MICROSPHERES CONTAINING THERAPEUTIC AGENTS AND ASSOCIATED METHODS OF USE
US12102781B2 (en) 2018-06-29 2024-10-01 Biosense Webster (Israel) Ltd. Reinforcement for irrigated electrophysiology balloon catheter with flexible-circuit electrodes
US12458436B2 (en) 2018-07-30 2025-11-04 Biosense Webster (Israel) Ltd. Flexible-circuit tip for a split-tip catheter
US11071585B2 (en) 2018-09-14 2021-07-27 Biosense Webster (Israel) Ltd. Systems and methods of ablating cardiac tissue
US12402867B2 (en) 2019-02-15 2025-09-02 C.R. Bard, Inc. Hemostatic biopsy tract article
USD968421S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
USD968422S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with transitional graphical user interface
USD969138S1 (en) 2019-05-31 2022-11-08 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
CN110204956A (zh) * 2019-07-15 2019-09-06 深圳市裕同包装科技股份有限公司 一种可生物降解绿色印刷油墨连接料、油墨及其制备方法
US12616515B2 (en) 2019-08-27 2026-05-05 Biosense Webster (Israel) Ltd. Estimation of electrode-tissue contact using stem and edge electrodes
US12369975B2 (en) 2019-09-12 2025-07-29 Biosense Webster (Israel) Ltd. Balloon catheter with force sensor
US11633228B2 (en) 2019-10-04 2023-04-25 Biosense Webster (Israel) Ltd. Identifying pulmonary vein occlusion by dimension deformations of balloon catheter
US12369974B2 (en) 2019-10-10 2025-07-29 Biosense Webster (Israel) Ltd. Touch indication of balloon-catheter ablation electrode via balloon surface temperature measurement
US12137967B2 (en) 2019-11-12 2024-11-12 Biosense Webster (Israel) Ltd. Accurate positioning and shape visualization of balloon catheter ablation tags
EP4121130A4 (de) * 2020-03-17 2024-03-27 MicroVention, Inc. Flüssige embolie
US12558154B2 (en) 2020-08-14 2026-02-24 Biosense Webster (Israel) Ltd. Balloon catheter having ablation and return electrodes
US12239364B2 (en) 2020-10-07 2025-03-04 Biosense Webster (Israel) Ltd. Printed proximal electrodes of an expandable catheter for use as a common electrode
US11974803B2 (en) 2020-10-12 2024-05-07 Biosense Webster (Israel) Ltd. Basket catheter with balloon
US12544128B2 (en) 2020-10-30 2026-02-10 Biosense Webster (Israel) Ltd. Balloon catheter with split electrodes
US11957852B2 (en) 2021-01-14 2024-04-16 Biosense Webster (Israel) Ltd. Intravascular balloon with slidable central irrigation tube
US11849995B2 (en) 2021-02-18 2023-12-26 Biosense Webster (Israel) Ltd. Detection of balloon catheter tissue contact using optical measurement
US12114905B2 (en) 2021-08-27 2024-10-15 Biosense Webster (Israel) Ltd. Reinforcement and stress relief for an irrigated electrophysiology balloon catheter with flexible-circuit electrodes
US12551270B2 (en) 2022-06-23 2026-02-17 Biosense Webster (Israel) Ltd. Graphical contact quality indicator for balloon catheter navigation
USD1115794S1 (en) 2022-06-23 2026-03-03 Biosense Webster (Israel) Ltd. Display screen with GUI for contact quality indicator of expandable end effectors in computer-aided electrophysiology navigation
WO2025159745A1 (en) * 2024-01-24 2025-07-31 Bard Peripheral Vascular, Inc. Embolic hydrogels for female sterilization

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2668156A (en) * 1950-04-06 1954-02-02 Nat Starch Products Inc Unsaturated starch compounds and insoluble derivatives thereof
US4060506A (en) * 1976-04-27 1977-11-29 A. E. Staley Manufacturing Company Starch acrylamides and the method for preparing the same
US4079025A (en) * 1976-04-27 1978-03-14 A. E. Staley Manufacturing Company Copolymerized starch composition
US4485224A (en) * 1983-09-02 1984-11-27 The Goodyear Tire & Rubber Company Acrylamide polymerization
AU604236B2 (en) * 1986-04-28 1990-12-13 Iolab, Inc. Intraocular dosage compositions and method of use
US5160745A (en) * 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4741872A (en) * 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
US5116927A (en) * 1989-06-27 1992-05-26 Sequa Chemicals, Inc. Starch polymer graft composition and method of preparation
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5736371A (en) * 1991-06-04 1998-04-07 A Et S Biovecteurs Biodegradable particulate vector for transporting molecules having biological activity
WO1993009176A2 (en) * 1991-10-29 1993-05-13 Clover Consolidated, Limited Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
JP3455217B2 (ja) * 1992-02-13 2003-10-14 バイオ−メトリック システムズ インコーポレイテッド 架橋マトリックス中の化学種の固定
DE4210334A1 (de) * 1992-03-30 1993-10-07 Stoess & Co Gelatine Biologisch abbaubares, wasserresistentes Polymer-Material
US6277899B1 (en) * 1992-08-03 2001-08-21 Novamont S.P.A. Biodegradable polymeric composition
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5272181A (en) * 1992-11-18 1993-12-21 Evergreen Solutions, Inc. Biodegradable expanded foam material
NZ258533A (en) * 1992-11-30 1996-08-27 Ciba Geigy Ag Vinyl ester and amide derivatives of a dicarboxylic acid cyclic-oligomeric carbohydrate half ester; use for forming contact lenses, as thickeners, surfactants and lens cleaning agents
SE500964C2 (sv) * 1993-01-19 1994-10-10 Medicarb Ab Fast bärare med modifierad yta varvid modifikationen åstadkommes genom en primer innehållande en polysackarid och förfarande för framställning av en sådan bärare
US5589577A (en) * 1993-04-07 1996-12-31 Alko Group Ltd. Applications and methods for the preparation of fatty acid esters of polysaccharides
US5773021A (en) * 1994-03-14 1998-06-30 Vetoquinol S.A. Bioadhesive ophthalmic insert
US5658592A (en) * 1994-05-13 1997-08-19 Kuraray Co., Ltd. Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
GB9514285D0 (en) * 1995-07-13 1995-09-13 Univ Nottingham Polymeric lamellar substrate particles for drug delivery
JP2997995B2 (ja) * 1995-09-13 2000-01-11 日本コーンスターチ株式会社 生分解性樹脂組成物の水系分散液
CA2173818A1 (fr) * 1996-04-10 1997-10-11 Francois Chouinard Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose
FR2753902B1 (fr) * 1996-09-27 1999-04-02 Ioualalen Karim Nouveau type de matrice ionique biodegradable de polarite interne modulable a polymere greffe
US5879707A (en) * 1996-10-30 1999-03-09 Universite De Montreal Substituted amylose as a matrix for sustained drug release
EP0842657A1 (de) * 1996-11-19 1998-05-20 OctoPlus B.V. Mikrosphären zur gesteuerten Freisetzung und Verfahren zur Herstellung dieser Mikrosphären
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
US20020039594A1 (en) * 1997-05-13 2002-04-04 Evan C. Unger Solid porous matrices and methods of making and using the same
EP1003569B1 (de) * 1997-08-11 2004-10-20 Allergan, Inc. Steriles retinoid enthaltendes biodegradierbares implantat mit verbesserter biocompatibilität und verfahren zu dessen herstellung
US6121027A (en) * 1997-08-15 2000-09-19 Surmodics, Inc. Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups
US6316522B1 (en) * 1997-08-18 2001-11-13 Scimed Life Systems, Inc. Bioresorbable hydrogel compositions for implantable prostheses
DE19737481A1 (de) * 1997-08-28 1999-03-04 Hoechst Ag Sphärische lineare Polysaccharide enthaltende Mikropartikel
US6284273B1 (en) * 1998-02-24 2001-09-04 Vincent Lenaerts Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
US6410044B1 (en) * 1998-03-19 2002-06-25 Surmodics, Inc. Crosslinkable macromers
US6007833A (en) * 1998-03-19 1999-12-28 Surmodics, Inc. Crosslinkable macromers bearing initiator groups
FR2780901B1 (fr) * 1998-07-09 2000-09-29 Coletica Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant
ATE297452T1 (de) * 1998-07-23 2005-06-15 Avebe Coop Verkoop Prod Klebemittelzusammensetzung
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
SE9803481D0 (sv) * 1998-10-13 1998-10-13 Pharmacia & Upjohn Ab Photocurable siloxane polymers
US6716445B2 (en) * 1999-04-12 2004-04-06 Cornell Research Foundation, Inc. Hydrogel entrapping therapeutic agent and stent with coating comprising this
ES2298135T3 (es) * 1999-04-12 2008-05-16 Cornell Research Foundation, Inc. Sistema formador de hidrogel con componentes hidrofobos e hidrofilos.
AU2001271059A1 (en) * 2000-07-17 2002-01-30 Green Bio Inc. Biodegradable articles obtained from enzymatically synthesized amylose
ATE547080T1 (de) * 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
SE517421C2 (sv) * 2000-10-06 2002-06-04 Bioglan Ab Mikropartiklar, lämpade för parenteral administration, väsentligen bestående av stärkelse med minst 85 % amylopektin och med reducerad molekylvikt, samt framställning därav
US6748954B2 (en) * 2000-10-27 2004-06-15 The Regents Of The University Of Michigan Drug release from polymer matrices through mechanical stimulation
US6586493B1 (en) * 2001-03-07 2003-07-01 Arizona Board Of Regents Arizona State University Polysaccharide-based hydrogels and pre-gel blends for the same
US7501157B2 (en) * 2001-06-26 2009-03-10 Accelr8 Technology Corporation Hydroxyl functional surface coating
JP2005526972A (ja) * 2002-05-02 2005-09-08 シファーゲン バイオシステムズ, インコーポレイテッド 多糖系ヒドロゲルをコーティングした表面を有するバイオチップ
DE10223310A1 (de) * 2002-05-24 2003-12-11 Biotronik Mess & Therapieg Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
US7862831B2 (en) * 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
CA2689424A1 (en) * 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
CA2509382A1 (en) * 2002-12-17 2004-07-08 Todd C. Zion Stimuli-responsive systems for controlled drug delivery
US20040192905A1 (en) * 2003-03-31 2004-09-30 Kulkarni Mohan Gopalkrishna Polymerizable monomers and process of preparation thereof
US20050025797A1 (en) * 2003-04-08 2005-02-03 Xingwu Wang Medical device with low magnetic susceptibility
US8021680B2 (en) * 2003-05-02 2011-09-20 Surmodics, Inc. Controlled release bioactive agent delivery device
CA2536042A1 (en) * 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
US20050133046A1 (en) * 2003-12-17 2005-06-23 Becker Timothy A. Compositions and methods for improved occlusion of vascular defects
WO2005071067A2 (en) * 2004-01-15 2005-08-04 Intervet International B.V. Non-animal origin stabilizers and processes for producing the same
WO2005113034A1 (en) * 2004-05-12 2005-12-01 Surmodics, Inc. Natural biodegradable polysaccharides coatings for medical articles
EP1778751B1 (de) * 2004-08-12 2017-03-01 Sherwin-Williams Luxembourg Investment Management Company S.à r.l. Alkydharze auf kohlenhydratbasis
WO2006050110A2 (en) * 2004-10-28 2006-05-11 Surmodics, Inc. Pro-fibrotic coatings comprising collagen for medical implants
CA2621595A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides

Also Published As

Publication number Publication date
US20070071792A1 (en) 2007-03-29
JP2009508646A (ja) 2009-03-05
JP5139302B2 (ja) 2013-02-06
CA2621657A1 (en) 2007-03-29
WO2007035865A1 (en) 2007-03-29
EP1926504A1 (de) 2008-06-04
CA2621597A1 (en) 2007-04-05
US20070065484A1 (en) 2007-03-22
JP2009508653A (ja) 2009-03-05
EP1926505B1 (de) 2012-02-01
CA2621657C (en) 2014-06-17
JP5226517B2 (ja) 2013-07-03
DE602006011764D1 (de) 2010-03-04
CA2621597C (en) 2014-06-10
EP1926504B1 (de) 2010-01-13
EP1926505A1 (de) 2008-06-04
ATE454908T1 (de) 2010-01-15
WO2007038126A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
ATE454908T1 (de) In situ okklusionszusammensetzungen mit natürlichen biologisch abbaubaren polysacchariden
WO2008073295A3 (en) Latent stabilization of bioactive agents releasable from implantable medical articles
IS8493A (is) Notkun á rótigótíni við meðhöndlun og forvörn a dópamín taugafrumumissi
MX2009004365A (es) Dispositivos oculares y metodos para la fabricacion y uso de los mismos.
ITRM20030210A1 (it) Protesi da impiegarsi nella terapia chirurgica del prolasso
AR086971A2 (es) Composiciones orales y sistemas de liberacion
WO2007104541A3 (en) Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders
NZ603913A (en) Method of engrafting cells from solid tissues
MX2010003774A (es) Formulaciones oftalmicas acuosas.
EP3351211C0 (de) Sklerale prothese zur behandlung von altersweitsichtigkeit und anderen augenerkrankungen
DE69513912D1 (de) Material zum tragen auf dem augapfel
HUE045953T2 (hu) Connexin 43 elleni gátló vegyületek és azok alkalmazási eljárásai szem szaruhártya trauma kezelésében
BRPI0509461A (pt) implantes intravìtreos compreendendo microesferas que encapsulam um inibidor de tirosina cinase e um polìmero biodegradável
EP2583978A3 (de) Verhinderung und Behandlung synukleinopathischer und amyloidogener Krankheiten
WO2009111317A3 (en) Endoscopic delivery of red/nir light to the substantia nigra to treat parkinson's disease
MX377802B (es) Metodos y composiciones para trastornos del sueño y otros trastornos.
TW200732347A (en) VEGF analogs and methods of use
MX375532B (es) Usos de inhibidores de dpp iv.
CR9427A (es) Combinacion terapeutica en casos de hiperplasia prostatica benigna
WO2008052145A3 (en) Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
CY1111384T1 (el) Διαμορφωση των επιπεδων εκφρασης toy trpv
EP2384769A3 (de) Ophthalmische Visualisierungszusammensetzungen und Verwendungsverfahren dafür
MD3905G2 (ro) Remediu medicamentos cu acţiune prelungită sub formă de gel pentru tratamentul afecţiunilor parodonţiului (variante)
FR2883182B1 (fr) Composition de vitamines utiles dans le traitement des maladies oculaires